重症急性肾损伤人群观察等待策略与早期启动肾脏替代治疗的比较:一项更新的系统评价与荟萃分析
该更新的系统评价与荟萃分析纳入9项RCT共1938例急性肾损伤患者,比较早期与晚期启动肾脏替代治疗。早期启动未提供生存获益(合并OR 0.88,95%CI 0.62-1.27),但机械通气天数显著减少(合并均数差-3.98天,95%CI -7.81至-0.15天)。亚组分析显示,纳入外科人群(P=0.001)和高血浆NGAL的AKI人群(P=0.031)的RCT在早期启动组中肾脏替代治疗天数有有利结局。基于传统启动指征的观察等待策略在主要和次要结局上均安全。
要点
- 早期启动肾脏替代治疗未提供生存获益:合并OR 0.88(95%CI 0.62-1.27)。
- 早期启动组机械通气天数显著减少:合并均数差-3.98天(95%CI -7.81至-0.15天)。
- 外科人群(P=0.001)和高血浆NGAL的AKI人群(P=0.031)的RCT中,早期启动组肾脏替代治疗天数有有利结局。
- 基于传统启动指征的观察等待策略在主要和次要结局上均安全。
- 共纳入9项RCT、1938例急性肾损伤患者。
适用人群与场景
- 急性肾损伤(AKI)重症患者;排除非AKI人群的试验。
研究设计与关键结果
- 系统评价与荟萃分析纳入9项RCT共1938例急性肾损伤患者,比较早期与晚期启动肾脏替代治疗。
- 早期启动肾脏替代治疗未提供生存获益:合并OR 0.88(95%CI 0.62-1.27)。
- 早期启动组机械通气天数显著减少:合并均数差-3.98天(95%CI -7.81至-0.15天)。
- 亚组分析显示,纳入外科人群的RCT(P=0.001)和高血浆NGAL的AKI人群的RCT(P=0.031)在早期启动组中肾脏替代治疗天数有有利结局。
- 9项RCT中6项用于评估观察等待策略的安全性,早期与晚期肾脏替代治疗组在主要和次要结局上均无显著差异。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入9项RCT。
- 局限:原文未报告局限性。
对床旁实践的改变
- 基于传统肾脏替代治疗启动指征,观察等待策略在主要和次要结局上安全。
- 早期启动肾脏替代治疗未提供生存获益,但可能减少机械通气天数。
- 在外科人群和高血浆NGAL的AKI患者中,早期启动可能缩短肾脏替代治疗或机械通气支持时间。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The optimal timing of renal replacement therapy (RRT) initiation is debatable. Many articles in this field enrolled trials not based on acute kidney injury. The safety of the watchful waiting strategy has not been fully discussed, and late RRT initiation criteria vary across studies. The effect of early RRT initiation in the AKI population with high plasma neutrophil gelatinase-associated lipocalin (NGAL) has not been examined yet.
METHODS: In accordance with PRISMA guidelines, the PubMed, Embase, and Cochrane databases were systemically searched for randomized controlled trials (RCTs). Trials not conducted in the AKI population were excluded. Data of study characteristics, primary outcome (all-cause mortality), and related secondary outcomes [mechanical ventilation (MV) days, length of hospital stay, RRT days, and length of ICU stay] were extracted. The outcomes were compared between early and late RRT groups by estimating the pooled odds ratio (OR) for binary outcomes and the weighted mean difference for continuous outcomes. Prospective trials were also examined and analyzed using the same method.
RESULTS: Nine RCTs with 1938 patients were included. Early RRT did not provide a survival benefit (pooled OR, 0.88; 95% confidence interval [CI] 0.62-1.27). However, the early RRT group had significantly fewer MV days (pooled mean difference, - 3.98 days; 95% CI - 7.81 to - 0.15 days). Subgroup analysis showed that RCTs enrolling the surgical population (P = .001) and the AKI population with high plasma NGAL (P = .031) had favorable outcomes regarding RRT days in the early initiation group. Moreover, 6 of 9 RCTs were selected for examining the safety of the watchful waiting strategy, and no significant differences were found in primary and secondary outcomes between the early and late RRT groups.
CONCLUSIONS: Overall, early RRT initiation did not provide a survival benefit, but a possible benefit of fewer MV days was detected. Early RRT might also provide the benefit of shorter MV or RRT support in the surgical population and in AKI patients with high plasma NGAL. Depending on the conventional indication for RRT initiation, the watchful waiting strategy is safe on the basis of all primary and secondary outcomes.
参考来源
- Chen JJ, Lee CC, Kuo G, et al. Comparison between watchful waiting strategy and early initiation of renal replacement therapy in the critically ill acute kidney injury population: an updated systematic review and meta-analysis. Ann Intensive Care. 2020. PMID: 32128633. doi:10.1186/s13613-020-0641-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。